Business Description
Gennex Laboratories Ltd
ISIN : INE509C01026
Compare
Compare
Traded in other countries / regions
531739.India IPO Date
2000-11-12Description
Gennex Laboratories Ltd is engaged in the manufacturing of bulk drugs, and intermediates, Biotech Products. Geographically, the group has a business presence in Bangladesh, Egypt, Germany, Guatemala, Iran, Israel and other countries. Its products include Guaifenesin, Methocarbamol, Fluconazole and Phenazopyridine, among others.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 20.33 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.26 | |||||
| Interest Coverage | 4.76 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.94 | |||||
| Beneish M-Score | -1.07 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.8 | |||||
| 3-Year EBITDA Growth Rate | 26.2 | |||||
| 3-Year EPS without NRI Growth Rate | 23 | |||||
| 3-Year FCF Growth Rate | -166.3 | |||||
| 3-Year Book Growth Rate | 35.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.5 | |||||
| 9-Day RSI | 29.68 | |||||
| 14-Day RSI | 34.86 | |||||
| 6-1 Month Momentum % | -9.02 | |||||
| 12-1 Month Momentum % | 150.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.01 | |||||
| Quick Ratio | 3.39 | |||||
| Cash Ratio | 2.88 | |||||
| Days Inventory | 156.6 | |||||
| Days Sales Outstanding | 56.78 | |||||
| Days Payable | 72.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.7 | |||||
| Shareholder Yield % | -1 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.66 | |||||
| Operating Margin % | 16.87 | |||||
| Net Margin % | 15.19 | |||||
| FCF Margin % | -53.84 | |||||
| ROE % | 11.72 | |||||
| ROA % | 7.99 | |||||
| ROIC % | 11.08 | |||||
| ROC (Joel Greenblatt) % | 27.54 | |||||
| ROCE % | 14.61 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.23 | |||||
| PE Ratio without NRI | 21.23 | |||||
| Shiller PE Ratio | 49.93 | |||||
| PEG Ratio | 0.98 | |||||
| PS Ratio | 3.3 | |||||
| PB Ratio | 1.88 | |||||
| Price-to-Tangible-Book | 1.92 | |||||
| EV-to-EBIT | 10.81 | |||||
| EV-to-EBITDA | 9.64 | |||||
| EV-to-Revenue | 2.44 | |||||
| EV-to-FCF | -4.61 | |||||
| Price-to-Projected-FCF | 8.09 | |||||
| Price-to-Median-PS-Value | 2.67 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.88 | |||||
| Price-to-Graham-Number | 1.35 | |||||
| Price-to-Net-Current-Asset-Value | 3.15 | |||||
| Price-to-Net-Cash | 5.69 | |||||
| Earnings Yield (Greenblatt) % | 9.25 | |||||
| FCF Yield % | -14.49 | |||||
| Forward Rate of Return (Yacktman) % | 16.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gennex Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 867.144 | ||
| EPS (TTM) (₹) | 0.667 | ||
| Beta | -0.03 | ||
| Volatility % | 53.14 | ||
| 14-Day RSI | 34.86 | ||
| 14-Day ATR (₹) | 0.775141 | ||
| 20-Day SMA (₹) | 15.2695 | ||
| 12-1 Month Momentum % | 150.75 | ||
| 52-Week Range (₹) | 6.15 - 21.89 | ||
| Shares Outstanding (Mil) | 227.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gennex Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gennex Laboratories Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Gennex Laboratories Ltd Frequently Asked Questions
What is Gennex Laboratories Ltd(BOM:531739)'s stock price today?
The current price of BOM:531739 is ₹14.16. The 52 week high of BOM:531739 is ₹21.89 and 52 week low is ₹6.15.
When is next earnings date of Gennex Laboratories Ltd(BOM:531739)?
The next earnings date of Gennex Laboratories Ltd(BOM:531739) is .
Does Gennex Laboratories Ltd(BOM:531739) pay dividends? If so, how much?
Gennex Laboratories Ltd(BOM:531739) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers